Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3930)
All Articles published online
|
Feb 14, 2010 (publication date) through Apr 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Hostettler L, Zlobec I, Terracciano L, Lugli A. ABCG5-positivity in tumor buds is an indicator of poor prognosis in node-negative colorectal cancer patients. World J Gastroenterol 2010; 16(6): 732-739 [PMID: 20135722 DOI: 10.3748/wjg.v16.i6.732] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v16/i6/732.htm |
| Number | Citing Articles |
| 1 |
David A. Margolin, Jennifer Silinsky, Chelsea Grimes, Nakia Spencer, Melissa Aycock, Heather Green, Jose Cordova, Nancy K. Davis, Tiffany Driscoll, Li Li. Lymph Node Stromal Cells Enhance Drug-Resistant Colon Cancer Cell Tumor Formation through SDF-1α/CXCR4 Paracrine Signaling. Neoplasia 2011; 13(9): 874 doi: 10.1593/neo.11324
|
| 2 |
Oğuzhan Okcu, Çiğdem Öztürk, Bayram Şen, Medeni Arpa, Recep Bedir. Tumor Budding is a reliable predictor for death and metastasis in invasive ductal breast cancer and correlates with other prognostic clinicopathological parameters. Annals of Diagnostic Pathology 2021; 54: 151792 doi: 10.1016/j.anndiagpath.2021.151792
|
| 3 |
Philipp Grosse‐Gehling, Christine A Fargeas, Claudia Dittfeld, Yvette Garbe, Malcolm R Alison, Denis Corbeil, Leoni A Kunz‐Schughart. CD133 as a biomarker for putative cancer stem cells in solid tumours: limitations, problems and challenges. The Journal of Pathology 2013; 229(3): 355 doi: 10.1002/path.4086
|
| 4 |
Claudio Rizzi, Palmina Cataldi, Aldo Iop, Miriam Isola, Riccardo Sgarra, Guidalberto Manfioletti, Vincenzo Giancotti. The expression of the high-mobility group A2 protein in colorectal cancer and surrounding fibroblasts is linked to tumor invasiveness. Human Pathology 2013; 44(1): 122 doi: 10.1016/j.humpath.2012.05.001
|
| 5 |
Heather Dawson, Alessandro Lugli. Molecular and Pathogenetic Aspects of Tumor Budding in Colorectal Cancer. Frontiers in Medicine 2015; 2 doi: 10.3389/fmed.2015.00011
|
| 6 |
Linde De Smedt, Sofie Palmans, Xavier Sagaert. Tumour budding in colorectal cancer: what do we know and what can we do?. Virchows Archiv 2016; 468(4): 397 doi: 10.1007/s00428-015-1886-5
|
| 7 |
P. Holy, A. Kloudova, P. Soucek. Importance of genetic background of oxysterol signaling in cancer. Biochimie 2018; 153: 109 doi: 10.1016/j.biochi.2018.04.023
|
| 8 |
Larissa Belov, Jerry Zhou, Richard I. Christopherson. Cell Surface Markers in Colorectal Cancer Prognosis. International Journal of Molecular Sciences 2010; 12(1): 78 doi: 10.3390/ijms12010078
|
| 9 |
Inti Zlobec. Novel biomarkers for the prediction of metastasis in colorectal cancer. Expert Opinion on Medical Diagnostics 2013; 7(2): 137 doi: 10.1517/17530059.2013.753054
|
| 10 |
I. Hlavata, B. Mohelnikova-Duchonova, R. Vaclavikova, V. Liska, P. Pitule, P. Novak, J. Bruha, O. Vycital, L. Holubec, V. Treska, P. Vodicka, P. Soucek. The role of ABC transporters in progression and clinical outcome of colorectal cancer. Mutagenesis 2012; 27(2): 187 doi: 10.1093/mutage/ger075
|
| 11 |
Tae-Hwa Baek, Dong-Wook Kang, Joo-Heon Kim, Hyun-Jin Son. Gland Attenuation, a Novel Morphological Feature of Colorectal Cancer: Evidence for an Epithelial-Mesenchymal Transition. Annals of Coloproctology 2018; 34(4): 187 doi: 10.3393/ac.2017.12.02
|
| 12 |
A Lugli, G Iezzi, I Hostettler, M G Muraro, V Mele, L Tornillo, V Carafa, G Spagnoli, L Terracciano, I Zlobec. Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM, and ALDH1 in colorectal cancer. British Journal of Cancer 2010; 103(3): 382 doi: 10.1038/sj.bjc.6605762
|
| 13 |
Alessandro Lugli, Richard Kirsch, Yoichi Ajioka, Fred Bosman, Gieri Cathomas, Heather Dawson, Hala El Zimaity, Jean-François Fléjou, Tine Plato Hansen, Arndt Hartmann, Sanjay Kakar, Cord Langner, Iris Nagtegaal, Giacomo Puppa, Robert Riddell, Ari Ristimäki, Kieran Sheahan, Thomas Smyrk, Kenichi Sugihara, Benoît Terris, Hideki Ueno, Michael Vieth, Inti Zlobec, Phil Quirke. Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016. Modern Pathology 2017; 30(9): 1299 doi: 10.1038/modpathol.2017.46
|
| 14 |
Thomas Brabletz. To differentiate or not — routes towards metastasis. Nature Reviews Cancer 2012; 12(6): 425 doi: 10.1038/nrc3265
|
| 15 |
Viktor Hendrik Koelzer, Bettina Huber, Valentina Mele, Giandomenica Iezzi, Mafalda Trippel, Eva Karamitopoulou, Inti Zlobec, Alessandro Lugli. Expression of the hyaluronan-mediated motility receptor RHAMM in tumor budding cells identifies aggressive colorectal cancers. Human Pathology 2015; 46(11): 1573 doi: 10.1016/j.humpath.2015.07.010
|
| 16 |
Michael Herman Chui. Insights into cancer metastasis from a clinicopathologic perspective: Epithelial‐Mesenchymal Transition is not a necessary step. International Journal of Cancer 2013; 132(7): 1487 doi: 10.1002/ijc.27745
|
| 17 |
Viktor H Koelzer, Alessandro Lugli. T-cell infiltrates and tumor budding: promising prognostic factors in the tumor microenvironment of colorectal cancer. Colorectal Cancer 2013; 2(3): 173 doi: 10.2217/crc.13.26
|
| 18 |
Maria De Angelis, Federica Francescangeli, Ann Zeuner, Marta Baiocchi. Colorectal Cancer Stem Cells: An Overview of Evolving Methods and Concepts. Cancers 2021; 13(23): 5910 doi: 10.3390/cancers13235910
|
| 19 |
Mariamena Arbitrio, Francesca Scionti, Maria Teresa Di Martino, Licia Pensabene, Pierfrancesco Tassone, Pierosandro Tagliaferri. Comprehensive Pharmacology. 2022; : 657 doi: 10.1016/B978-0-12-820472-6.00013-X
|
| 20 |
Willam Sterlacci, Spasenija Savic, Michael Fiegl, Ellen Obermann, Alexandar Tzankov. Putative Stem Cell Markers in Non–Small-Cell Lung Cancer: A Clinicopathologic Characterization. Journal of Thoracic Oncology 2014; 9(1): 41 doi: 10.1097/JTO.0000000000000021
|
| 21 |
Shrikant Pawar, Aditya Stanam, Rushikesh Ganesh Chopade. Machine learning for identification and characterization of molecular gene signatures in progression of benign tumors. 2021 2nd International Conference on Artificial Intelligence and Information Systems 2021; : 1 doi: 10.1145/3469213.3469214
|
| 22 |
Sonay Kus Öztürk, Tariq S. Haddad, Inti Zlobec, Alessandro Lugli, Iris D. Nagtegaal. Attackers and defenders: tumor buds and lymphocytes as morphological biomarkers in colorectal cancer. Diagnostic Histopathology 2022; 28(11): 480 doi: 10.1016/j.mpdhp.2022.08.002
|
| 23 |
Viktor H. Koelzer, Rupert Langer, Inti Zlobec, Alessandro Lugli. Tumor Budding in Upper Gastrointestinal Carcinomas. Frontiers in Oncology 2014; 4 doi: 10.3389/fonc.2014.00216
|
| 24 |
Alessandro Lugli, Inti Zlobec, Martin D. Berger, Richard Kirsch, Iris D. Nagtegaal. Tumour budding in solid cancers. Nature Reviews Clinical Oncology 2021; 18(2): 101 doi: 10.1038/s41571-020-0422-y
|
| 25 |
Lara P. Fernández, Marta Gómez de Cedrón, Ana Ramírez de Molina. Alterations of Lipid Metabolism in Cancer: Implications in Prognosis and Treatment. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.577420
|
| 26 |
Heather Dawson, Sandra Grundmann, Viktor H Koelzer, José A Galván, Richard Kirsch, Eva Karamitopoulou, Alessandro Lugli, Daniel Inderbitzin, Inti Zlobec. Tyrosine kinase receptor B (TrkB) expression in colorectal cancers highlights anoikis resistance as a survival mechanism of tumour budding cells. Histopathology 2015; 66(5): 715 doi: 10.1111/his.12603
|
| 27 |
Alessandro Sgambato, Maddalena Corbi, Maria Svelto, Emanuele Caredda, Achille Cittadini. Prominin-1 (CD133): New Insights on Stem & Cancer Stem Cell Biology. Advances in Experimental Medicine and Biology 2013; 777: 145 doi: 10.1007/978-1-4614-5894-4_10
|
| 28 |
Viktor H Koelzer, Inti Zlobec, Alessandro Lugli. Tumor budding in the clinical management of colon and rectal cancer. Colorectal Cancer 2014; 3(4): 387 doi: 10.2217/crc.14.21
|
| 29 |
|
| 30 |
Andreas H Marx, Claudius Mickler, Guido Sauter, Ronald Simon, Luigi M Terracciano, Jakob R Izbicki, Till S Clauditz. High-grade intratumoral tumor budding is a predictor for lymphovascular invasion and adverse outcome in stage II colorectal cancer. International Journal of Colorectal Disease 2020; 35(2): 259 doi: 10.1007/s00384-019-03478-w
|
| 31 |
M.P. Ween, M.A. Armstrong, M.K. Oehler, C. Ricciardelli. The role of ABC transporters in ovarian cancer progression and chemoresistance. Critical Reviews in Oncology/Hematology 2015; 96(2): 220 doi: 10.1016/j.critrevonc.2015.05.012
|
| 32 |
Inti Zlobec, Alessandro Lugli. Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: Tumor budding as oncotarget. Oncotarget 2010; 1(7): 651 doi: 10.18632/oncotarget.199
|
| 33 |
Jinhuang Chen, Qinghua Xia, Bin Jiang, Weilong Chang, Wenzheng Yuan, Zhijun Ma, Zhengyi Liu, Xiaogang Shu, Hiromu Suzuki. Prognostic Value of Cancer Stem Cell Marker ALDH1 Expression in Colorectal Cancer: A Systematic Review and Meta-Analysis. PLOS ONE 2015; 10(12): e0145164 doi: 10.1371/journal.pone.0145164
|
| 34 |
Shaoqiu Zheng, Jing Luo, Shoucheng Xie, Shanming Lu, Qinghua Liu, Huanqin Xiao, Wenjuan Luo, Yanfang Huang, Kun Liu. Tumor budding of cervical squamous cell carcinoma: epithelial-mesenchymal transition-like cancer stem cells?. PeerJ 2022; 10: e13745 doi: 10.7717/peerj.13745
|
| 35 |
Shuo-Meng Xiao, Jian Li. Tumor budding in gastric cancer. World Journal of Gastrointestinal Surgery 2023; 15(4): 578-591 doi: 10.4240/wjgs.v15.i4.578
|
| 36 |
Aleksandra Zeljkovic, Jelena Vekic, Marija Mihajlovic, Tamara Gojkovic, Sandra Vladimirov, Dejan Zeljkovic, Vesna Spasojevic-Kalimanovska, Bratislav Trifunovic. Revealing the Role of High-Density Lipoprotein in Colorectal Cancer. International Journal of Molecular Sciences 2021; 22(7): 3352 doi: 10.3390/ijms22073352
|
| 37 |
Panagiotis Kampilafkos, Maria Melachrinou, Zinovia Kefalopoulou, John Lakoumentas, Georgia Sotiropoulou-Bonikou. Epigenetic Modifications in Cutaneous Malignant Melanoma. The American Journal of Dermatopathology 2015; 37(2): 138 doi: 10.1097/DAD.0b013e31828a2d54
|
| 38 |
Mengying Tong, Ziqian Deng, Mengying Yang, Chang Xu, Xiaolong Zhang, Qingzheng Zhang, Yuwei Liao, Xiaodi Deng, Dekang Lv, Xuehong Zhang, Yu Zhang, Peiying Li, Luyao Song, Bicheng Wang, Aisha Al‐Dherasi, Zhiguang Li, Quentin Liu. Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells. Cancer Communications 2018; 38(1): 1 doi: 10.1186/s40880-018-0326-8
|
| 39 |
Katharina M. Scheurlen, Julia H. Chariker, Ziad Kanaan, Andrew B. Littlefield, Joan B. George, Caden Seraphine, Andre Rochet, Eric C. Rouchka, Susan Galandiuk. The NOTCH4-GATA4-IRG1 axis as a novel target in early-onset colorectal cancer. Cytokine & Growth Factor Reviews 2022; 67: 25 doi: 10.1016/j.cytogfr.2022.06.002
|
| 40 |
Sara N. Meyer, José A. Galván, Stefan Zahnd, Lena Sokol, Heather Dawson, Alessandro Lugli, Inti Zlobec. Co-expression of cytokeratin and vimentin in colorectal cancer highlights a subset of tumor buds and an atypical cancer-associated stroma. Human Pathology 2019; 87: 18 doi: 10.1016/j.humpath.2019.02.002
|